Use fundamental data analysis to check all available reported financial drivers of D N A to find out if markets are at this moment mispricing the company. We found twenty-three available fundamental indicators for D N A Biomedical Solutions Ltd which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all D N A fundamentals including its Cash and Equivalents, Beta, Current Liabilities, as well as the relationship between Cash Flow from Operations and Retained Earnings . Use D N to protect your portfolios against small markets fluctuations. The stock experiences normal downward trend and little activity. Check odds of D N to be traded at S26.04 in 30 days.
Chance of Financial Distress
D N A Biomedical Solutions Ltd has more than 89 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info
D N competes with Compugen Ltd, Kamada Ltd, Pluristem Therapeutics, BioLine Rx, and Evogene Ltd. D.N.A Biomedical Solutions Ltd. develops and commercializes laser spectrometry-based trace detection systems in Israel. D.N.A Biomedical Solutions Ltd. was founded in 2004 and is based in Ramat Gan, Israel. D N operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange.
D N A Biomedical Solutions Ltd is rated # 2 in price to earning category among related companies. It is rated below average in current ratio category among related companies . The ratio of Price to Earning to Current Ratio for D N A Biomedical Solutions Ltd is about 753.00
D N A Systematic Risk
The output start index for this execution was twenty-four with a total number of output elements of fifteen. The Beta measures systematic risk based on how returns on D N A correlated with the market. If Beta is less than 0 D N generally moves in the opposite direction as compared to the market. If D N Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one D N A is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of D N is generally in the same direction as the market. If Beta > 1 D N moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.